Oramed Pharmaceuticals (ORMP) Revenue & Revenue Breakdown
Oramed Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$1.34M
Oramed Pharmaceuticals Revenue by Period
Oramed Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.34M | -50.43% |
| 2022-12-31 | $2.70M | - |
| 2021-08-31 | $2.70M | -0.26% |
| 2020-08-31 | $2.71M | 0.26% |
| 2019-08-31 | $2.70M | 10.37% |
| 2018-08-31 | $2.45M | -0.29% |
| 2017-08-31 | $2.46M | 283.15% |
| 2016-08-31 | $641.00K | 100.00% |
| 2015-08-31 | - | 100.00% |
| 2014-08-31 | - | 100.00% |
| 2013-08-31 | - | -100.00% |
| 2012-08-31 | $184.25K | -6.67% |
| 2011-08-31 | $197.41K | 100.00% |
| 2010-08-31 | - | 100.00% |
| 2009-08-31 | - | 100.00% |
| 2008-08-31 | - | 100.00% |
| 2007-08-31 | - | 100.00% |
| 2006-08-31 | - | 100.00% |
| 2005-08-31 | - | 100.00% |
| 2004-08-31 | - | 100.00% |
| 2003-08-31 | - | - |
Oramed Pharmaceuticals generated $1.34M in revenue during NA 2023, up -50.43% compared to the previous quarter, and up 54.72% compared to the same period a year ago.
Oramed Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | -100.00% |
| 2025-03-31 | $2.00M | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | -100.00% |
| 2023-06-30 | $674.00K | 1.20% |
| 2023-03-31 | $666.00K | -2.20% |
| 2022-12-31 | $681.00K | -0.15% |
| 2022-09-30 | $682.00K | 1.19% |
| 2022-06-30 | $674.00K | 1.20% |
| 2022-03-31 | $666.00K | -1.19% |
| 2021-11-30 | $674.00K | -1.32% |
| 2021-08-31 | $683.00K | 0.29% |
| 2021-05-31 | $681.00K | 2.41% |
| 2021-02-28 | $665.00K | -1.34% |
| 2020-11-30 | $674.00K | -1.03% |
| 2020-08-31 | $681.00K | - |
| 2020-05-31 | $681.00K | 1.04% |
| 2020-02-29 | $674.00K | - |
| 2019-11-30 | $674.00K | -1.03% |
| 2019-08-31 | $681.00K | -0.15% |
| 2019-05-31 | $682.00K | 2.40% |
| 2019-02-28 | $666.00K | -1.19% |
| 2018-11-30 | $674.00K | 9.24% |
| 2018-08-31 | $617.00K | - |
| 2018-05-31 | $617.00K | 2.15% |
| 2018-02-28 | $604.00K | -1.15% |
| 2017-11-30 | $611.00K | -1.13% |
| 2017-08-31 | $618.00K | 0.16% |
| 2017-05-31 | $617.00K | 0.98% |
| 2017-02-28 | $611.00K | 0.16% |
| 2016-11-30 | $610.00K | 72.80% |
| 2016-08-31 | $353.00K | 116.56% |
| 2016-05-31 | $163.00K | 30.40% |
| 2016-02-29 | $125.00K | 100.00% |
| 2015-11-30 | - | 100.00% |
| 2015-08-31 | - | 100.00% |
| 2015-05-31 | - | 100.00% |
| 2015-02-28 | - | 100.00% |
| 2014-11-30 | - | 100.00% |
| 2014-08-31 | - | 100.00% |
| 2014-05-31 | - | 100.00% |
| 2014-02-28 | - | 100.00% |
| 2013-11-30 | - | 100.00% |
| 2013-08-31 | - | 100.00% |
| 2013-05-31 | - | 100.00% |
| 2013-02-28 | - | 100.00% |
| 2012-11-30 | - | 100.00% |
| 2012-08-31 | - | 100.00% |
| 2012-05-31 | - | 100.00% |
| 2012-02-29 | - | 100.00% |
| 2011-11-30 | - | 100.00% |
| 2011-08-31 | - | 100.00% |
| 2011-05-31 | - | 100.00% |
| 2011-02-28 | - | 100.00% |
| 2010-11-30 | - | 100.00% |
| 2010-08-31 | - | 100.00% |
| 2010-05-31 | - | 100.00% |
| 2010-02-28 | - | 100.00% |
| 2009-11-30 | - | 100.00% |
| 2009-08-31 | - | 100.00% |
| 2009-05-31 | - | 100.00% |
| 2009-02-28 | - | 100.00% |
| 2008-11-30 | - | 100.00% |
| 2008-08-31 | - | 100.00% |
| 2008-05-31 | - | 100.00% |
| 2007-11-30 | - | - |
Oramed Pharmaceuticals generated - in revenue during Q2 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Oramed Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COYA | Coya Therapeutics | $3.55B | $3.56B |
| MGNX | MacroGenics | $149.96M | $22.24M |
| CNTB | Connect Biopharma | $26.03M | $48.00K |
| STTK | Shattuck Labs | $5.72M | - |
| ORMP | Oramed Pharmaceuticals | $1.34M | - |
| OVID | Ovid Therapeutics | $566.00K | $132.00K |
| CLNN | Clene | $342.00K | $15.00K |
| IFRX | InflaRx | $61.80K | $36.25K |
| CNTX | Context Therapeutics | - | - |
| KLRS | Kalaris Therapeutics | - | - |
| IMA | ImageneBio | - | - |